Equity Overview
Price & Market Data
Price: $18.53
Daily Change: $0.00 / 0.00%
Range: $0 - $0
Market Cap: $2,224,971,264
Volume: 0
Performance Metrics
1 Week: -5.31%
1 Month: -34.08%
3 Months: -17.98%
6 Months: -17.98%
1 Year: -17.98%
YTD: -30.08%
Company Details
Employees: 81
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Metsera, Inc., a clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases. It develops MET-097i and MET-233i for the treatment of obesity and overweight; MET-233i/MET-097i; and MET-002, MET-224o, MET-067i, and MET-034i to treat disorders, such as diabetes and obesity, as well as MET-815i to reduce weight or prevents weight gain. The company was incorporated in 2022 and is based in New York, New York.